Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Acrux ( (AU:ACR) ).
Acrux Ltd has announced a change in the interest of its director, Don Brumley, who has increased his holdings by acquiring 448,334 ordinary shares through the exercise of vested unlisted rights issued in 2024. This change reflects a strategic move by the director to increase his stake in the company, potentially signaling confidence in Acrux’s future performance and aligning his interests more closely with those of the shareholders.
More about Acrux
Acrux Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of innovative drug delivery solutions. The company primarily offers products that enhance the delivery of medications through the skin, targeting various therapeutic areas and aiming to improve patient outcomes.
Average Trading Volume: 271,212
Technical Sentiment Signal: Sell
Current Market Cap: A$9.78M
Find detailed analytics on ACR stock on TipRanks’ Stock Analysis page.